Cidara Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
12 May 2025	Form 3: Davarpanah Nicole Negar, Chief Medical Officer Holds 21,692 shares of Common Stock
26 Feb 2025	Form 3: Karbe Frank, Chief Financial Officer No securities owned
07 Jan 2025	Form 3: Resnick Joshua, Director No securities owned
30 Apr 2024	Form 3: Ra Capital MANAGEMENT, L.p., Director and 3 others No securities owned
30 Apr 2024	Form 3: Spencer Ryan, Director No securities owned
30 Apr 2024	Form 3: Merson James, Director No securities owned
30 Apr 2024	Form 3: Tadvalkar Laura, Director No securities owned
03 Sep 2021	Form 3: Shah Preetam, CFO & CBO No securities owned
27 Aug 2021	Form 3: Ward Shane, CHIEF LEGAL OFFICER No securities owned
19 Jul 2021	Form 3: Johnson Brady, Vice President, Finance Holds 26,369 shares of Common Stock
06 Jul 2021	Form 3: Tari Leslie, Chief Scientific Officer Holds 2,551 shares of Common Stock
25 Jan 2021	Form 3: Canale-Theakston Carin, Director No securities owned
25 Jan 2021	Form 3: Bassler Bonnie L, Director Holds 312 shares of Common Stock
13 Sep 2019	Form 3: Mundipharma Ag, 10% owner Holds 4,781,408 shares of Common Stock, $0.0001 par value per share
04 Dec 2018	Form 3: Levine James E., Chief Financial Officer No securities owned
04 Dec 2018	Form 3: Oien Jessica, General Counsel & Secretary
12 Sep 2018	Form 3: Gollaher David L, Director No securities owned
28 Aug 2018	Form 3: Johnson Brady, Dir. of Finance & Controller Holds 3,721 shares of Common Stock
01 Mar 2018	Form 3: Mineo Chrysa, Director No securities owned
27 Oct 2017	Form 3: Biotech Target N V, 10% owner and 1 other Holds 2,235,272 shares of Common Stock

Comments